Search hospitals > California > Harbor City
Kaiser Permanente - Harbor City
Claim this profileHarbor City, California 90710
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
119 reported clinical trials
8 medical researchers
Summary
Kaiser Permanente - Harbor City is a medical facility located in Harbor City, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Kaiser Permanente - Harbor City is involved with conducting 119 clinical trials across 288 conditions. There are 8 research doctors associated with this hospital, such as Gary L. Buchschacher, Helen H. Moon, Eric C. McGary, and Ashraf R. Aziz.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Gary L. BuchschacherKaiser Permanente-Anaheim6 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
12 reported clinical trials
33 drugs studied
Helen H. MoonKaiser Permanente-Riverside7 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
13 reported clinical trials
23 drugs studied
Eric C. McGaryKaiser Permanente-Anaheim9 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
18 drugs studied
Ashraf R. AzizKaiser Permanente-Baldwin Park5 years of reported clinical research
Studies Lymphoma
Studies Leukemia
10 reported clinical trials
30 drugs studied
Clinical Trials running at Kaiser Permanente - Harbor City
Non-Small Cell Lung Cancer
Breast Cancer
Lung Cancer
Prostate Cancer
Diffuse Large B-Cell Lymphoma
Cancer
Lymphoma
Colorectal Cancer
Small Intestinal Adenocarcinoma
Anal Squamous Cell Carcinoma
Sotorasib
for Non-Small Cell Lung Cancer
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente - Harbor City?
Kaiser Permanente - Harbor City is a medical facility located in Harbor City, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Kaiser Permanente - Harbor City is involved with conducting 119 clinical trials across 288 conditions. There are 8 research doctors associated with this hospital, such as Gary L. Buchschacher, Helen H. Moon, Eric C. McGary, and Ashraf R. Aziz.